182 related articles for article (PubMed ID: 18644116)
1. Regulation of vascular endothelial growth factor expression by homeodomain-interacting protein kinase-2.
Puca R; Nardinocchi L; D'Orazi G
J Exp Clin Cancer Res; 2008 Jul; 27(1):22. PubMed ID: 18644116
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HIF-1alpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis.
Nardinocchi L; Puca R; Sacchi A; D'Orazi G
Mol Cancer; 2009 Jan; 8():1. PubMed ID: 19128456
[TBL] [Abstract][Full Text] [Related]
3. Homeodomain-interacting protein kinase 2 (HIPK2) targets beta-catenin for phosphorylation and proteasomal degradation.
Kim EA; Kim JE; Sung KS; Choi DW; Lee BJ; Choi CY
Biochem Biophys Res Commun; 2010 Apr; 394(4):966-71. PubMed ID: 20307497
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of hypoxia-inducible factor 1alpha by HIPK2 suggests a novel mechanism to restrain tumor growth.
Nardinocchi L; Puca R; Guidolin D; Belloni AS; Bossi G; Michiels C; Sacchi A; Onisto M; D'Orazi G
Biochim Biophys Acta; 2009 Feb; 1793(2):368-77. PubMed ID: 19046997
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.
Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM
J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231
[TBL] [Abstract][Full Text] [Related]
6. Targeting COX-2/PGE(2) pathway in HIPK2 knockdown cancer cells: impact on dendritic cell maturation.
Garufi A; Pistritto G; Ceci C; Di Renzo L; Santarelli R; Faggioni A; Cirone M; D'Orazi G
PLoS One; 2012; 7(11):e48342. PubMed ID: 23144866
[TBL] [Abstract][Full Text] [Related]
7. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
[TBL] [Abstract][Full Text] [Related]
8. Loss of p53, rather than beta-catenin overexpression, induces survivin-mediated resistance to apoptosis in an esophageal cancer cell line.
Chang E; Donahue J; Smith A; Hornick J; Rao JN; Wang JY; Battafarano RJ
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):225-32. PubMed ID: 20236666
[TBL] [Abstract][Full Text] [Related]
9. Hyperglycemia triggers HIPK2 protein degradation.
Baldari S; Garufi A; Granato M; Cuomo L; Pistritto G; Cirone M; D'Orazi G
Oncotarget; 2017 Jan; 8(1):1190-1203. PubMed ID: 27901482
[TBL] [Abstract][Full Text] [Related]
10. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
Di Stefano V; Soddu S; Sacchi A; D'Orazi G
Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of TCF proteins by homeodomain-interacting protein kinase 2.
Hikasa H; Sokol SY
J Biol Chem; 2011 Apr; 286(14):12093-100. PubMed ID: 21285352
[TBL] [Abstract][Full Text] [Related]
12. Homeodomain-interacting protein kinase-2 restrains cytosolic phospholipase A2-dependent prostaglandin E2 generation in human colorectal cancer cells.
D'Orazi G; Sciulli MG; Di Stefano V; Riccioni S; Frattini M; Falcioni R; Bertario L; Sacchi A; Patrignani P
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):735-41. PubMed ID: 16467083
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of hypoxia inducible factor-1α downregulates the expression of epithelial to mesenchymal transition early marker proteins without undermining cell survival in hypoxic lens epithelial cells.
Cammarata PR; Neelam S; Brooks MM
Mol Vis; 2015; 21():1024-35. PubMed ID: 26392741
[TBL] [Abstract][Full Text] [Related]
14. Novel regulation of vascular endothelial growth factor-A (VEGF-A) by transforming growth factor (beta)1: requirement for Smads, (beta)-CATENIN, AND GSK3(beta).
Clifford RL; Deacon K; Knox AJ
J Biol Chem; 2008 Dec; 283(51):35337-53. PubMed ID: 18952601
[TBL] [Abstract][Full Text] [Related]
15. Tolfenamic acid downregulates β-catenin in colon cancer.
Ha T; Lou Z; Baek SJ; Lee SH
Int Immunopharmacol; 2016 Jun; 35():287-293. PubMed ID: 27089389
[TBL] [Abstract][Full Text] [Related]
16. The aurora kinase A regulates GSK-3beta in gastric cancer cells.
Dar AA; Belkhiri A; El-Rifai W
Oncogene; 2009 Feb; 28(6):866-75. PubMed ID: 19060929
[TBL] [Abstract][Full Text] [Related]
17. TNF-α mediates choroidal neovascularization by upregulating VEGF expression in RPE through ROS-dependent β-catenin activation.
Wang H; Han X; Wittchen ES; Hartnett ME
Mol Vis; 2016; 22():116-28. PubMed ID: 26900328
[TBL] [Abstract][Full Text] [Related]
18. Differential role of beta-catenin in VEGF and histamine-induced MMP-2 production in microvascular endothelial cells.
Doyle JL; Haas TL
J Cell Biochem; 2009 May; 107(2):272-83. PubMed ID: 19306293
[TBL] [Abstract][Full Text] [Related]
19. Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity.
Song S; Mazurek N; Liu C; Sun Y; Ding QQ; Liu K; Hung MC; Bresalier RS
Cancer Res; 2009 Feb; 69(4):1343-9. PubMed ID: 19190323
[TBL] [Abstract][Full Text] [Related]
20. Adeno-sh-beta-catenin abolishes ischemic preconditioning-mediated cardioprotection by downregulation of its target genes VEGF, Bcl-2, and survivin in ischemic rat myocardium.
Thirunavukkarasu M; Han Z; Zhan L; Penumathsa SV; Menon VP; Maulik N
Antioxid Redox Signal; 2008 Aug; 10(8):1475-84. PubMed ID: 18407748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
